Maekawa A, Onodera H, Tanigawa H, Furuta K, Kanno J, Mochizuki M, Takeda K, Okada M
Carcinogenesis. 1986 Aug;7(8):1313-6. doi: 10.1093/carcin/7.8.1313.
As model compounds of alpha-hydroxy N-nitrosamines, four alpha-hydroperoxy N-nitrosamines were tested for their carcinogenic potential in F344 rats by i.v. injections. Correlation between chemical structure and carcinogenic potencies with respect to target organs was examined. Compounds used in this study were N-methyl-N-(hydroperoxymethyl)nitrosamine (MHPMN), N-ethyl-N-(1-hydroperoxyethyl)nitrosamine (EHPEN), N-propyl-N-(1-hydroperoxypropyl)nitrosamine (PHPPN) and N-butyl-N-(1-hydroperoxybutyl)nitrosamine (BHPBN). All chemicals were dissolved in distilled water and rats received 10 X 1 weekly i.v. injections of these chemicals (10 X 1 weekly injection of 5 mg/kg of MHPMN or equimolar amounts of other chemicals). Lung tumors were detected in all groups of both sexes and the incidences were 100% in each group. Thyroid tumors were also observed with relatively high incidences in treated groups except BHPBN. In the control group, tumors were observed mainly in the testis or uterus, and only two lung tumors and one thyroid tumor were observed in females. Histologically, all lung tumors in the MHPMN group were adenocarcinomas, squamous cell carcinomas or a mixture of both types. In the EHPEN, PHPPN and BHPBN groups, especially in females, incidences of carcinomas decreased as the length of the alkyl chain of the compounds, and most of lung tumors in females of the PHPPN and BHPBN groups were adenomas. Many of the thyroid tumors observed in the treated groups were follicular adenomas/carcinomas, whereas C-cell adenomas were the most common type of spontaneous thyroid tumors in this strain of rats. These target organs were similar to those of alpha-acetoxy N-nitrosamines reported previously. The results indicate that the carcinogenic activities of these chemicals depend on the length of the alkyl chain and that organ specificity of these chemicals may differ from those of their mother compounds.
作为α-羟基N-亚硝胺的模型化合物,通过静脉注射对四种α-氢过氧N-亚硝胺在F344大鼠中的致癌潜力进行了测试。研究了化学结构与针对靶器官的致癌效力之间的相关性。本研究中使用的化合物为N-甲基-N-(氢过氧甲基)亚硝胺(MHPMN)、N-乙基-N-(1-氢过氧乙基)亚硝胺(EHPEN)、N-丙基-N-(1-氢过氧丙基)亚硝胺(PHPPN)和N-丁基-N-(1-氢过氧丁基)亚硝胺(BHPBN)。所有化学物质均溶解于蒸馏水中,大鼠每周接受10次静脉注射这些化学物质(每周10次注射5mg/kg的MHPMN或等摩尔量的其他化学物质)。在所有性别组中均检测到肺部肿瘤,每组的发生率均为100%。除BHPBN外,在治疗组中也观察到甲状腺肿瘤的相对高发生率。在对照组中,肿瘤主要在睾丸或子宫中观察到,在雌性中仅观察到2个肺部肿瘤和1个甲状腺肿瘤。组织学上,MHPMN组中的所有肺部肿瘤均为腺癌、鳞状细胞癌或两种类型的混合。在EHPEN、PHPPN和BHPBN组中,尤其是在雌性中,随着化合物烷基链长度的增加,癌的发生率降低,并且PHPPN和BHPBN组雌性中的大多数肺部肿瘤为腺瘤。在治疗组中观察到的许多甲状腺肿瘤为滤泡性腺瘤/癌,而C细胞腺瘤是该品系大鼠中最常见的自发性甲状腺肿瘤类型。这些靶器官与先前报道的α-乙酰氧基N-亚硝胺的靶器官相似。结果表明,这些化学物质的致癌活性取决于烷基链的长度,并且这些化学物质的器官特异性可能与其母体化合物不同。